Junze Wang
6 Papers
Junze Wang is an academic researcher. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 2, co-authored 6 publications.
Chat about Author
Papers
Gas Migration Model for Non-Newtonian Fluids Under Shut-In Well Conditions
Yaxin Liu,Eric R. Upchurch,Evren Ozbayoglu,Silvio Baldino,Danzhu Zheng,Junze Wang +5 more
- 07 Mar 2023
TL;DR: In this paper , an improved gas migration velocity model was developed by combining the equation of motion (bubble flow) and Taylor-bubble correlation (slug flow), where the effects of non-Newtonian fluid properties and drill pipe rotation are considered through a modified drag coefficient (CD) that incorporates the bubble Reynolds number (Reb) and dimensionless shear rate (Sr).
19
Redox-sensitive hyaluronic acid-ferrocene micelles delivering doxorubicin for enhanced tumor treatment by synergistic chemo/chemodynamic therepay
Fuwei Yang,Ping Wei,Meiyang Yang,Weijun Chen,Bingke Zhao,Wenhua Li,Junze Wang,Lihua Qiu,Jinghua Chen +8 more
TL;DR: In this paper , a targeting redox-sensitive micellar system (DOX/FCH) composed of ferrocene (Fc) and hyaluronic acid (HA) was prepared to deliver DOX for synergetic chemotherapy and chemodynamic therapy (CDT).
11
Enzyme-loaded glycogen nanoparticles with tumor-targeting Activatable host-guest supramolecule for augmented chemodynamic therapy.
Fuwei Yang,Wenjie Fang,Meiyang Yang,Weijun Chen,Jiamin Xu,Junze Wang,Wen-Hua Li,Bingke Zhao,Lihua Qiu,Jinghua Chen +9 more
TL;DR: In this paper , a new targeted separable [email protected]/HC nanoparticle system was developed to deliver glucose oxidase (GOx) for CDT/starvation tumor therapy.
7
Tumor-targeted glycogen nanoparticles loaded with hemin and glucose oxidase to promote tumor synergistic therapy.
Lihua Qiu,Junze Wang,Mariana Maciel Conceição,Shenhuan Liu,Meiyang Yang,Weijun Chen,Miaomiao Long,Matthew J. A. Wood,Jinghua Chen +8 more
TL;DR: In this paper , a novel tumor-targeted glycogen-based nanoparticle system (GN/He/GOx/HA) was developed to co-deliver hemin (He) and GOx, which can self-supply glucose formed upon degradation of glycogen by α-glycosidase in the lysosome environment, in order to achieve synergistic antitumor therapy.
5